Jagsonpal Pharmaceuticals Ltd.'s total assets for Q4 2025 were ₹2.78B, an increase of Infinity% from the previous quarter. IN:JAGSNPHARM total liabilities were ₹383.10M for the fiscal quarter, a -119.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.